Menopause - Women Stop Taking Hormone Pills?
Menopause - Women Stop Taking Hormone Pills?
Women, who have replaced the natural decline in hormones during menopause through the powder, have twice as many cases of breast cancer. A new study by Valerie Berol Englishwomen, which was published in the Lancet medical profession revealed that the commonly used hormonal treatment for women during their menopause is, issued twice a greater risk that they will develop breast cancer.
Austere news agency finding of research reports not specifically commented on, and so in public, massaged more catastrophic flood of messages, said communication did not leave any serious consequences. We men, we usually think, that we turn up so it does not. Gentle sex seems to give the impression that researchers have once again make mosquito camel. After all, millions of women who are in transition, taking hormonal preparations.
Those of you who get to the original source and you read carefully you will find that the author provides a somewhat unusually, in addition to myself, another co-author - and I quote, "Millions of women cooperating." In other words, so we have to do with new knowledge that has resulted in an investigation million cases! We do not have to be an expert in statistics to realize that if on such a large file (million women) found twice the difference of cancer in treated and untreated, they may mistake in finding that the culprit is hormonal therapy, virtually ruled out.
The worst affected are women who manage their consumption cycle of pills containing the substance with the effect of both estrogen and progesterone. For this approach to use the term combined hormone therapy. These cases, in practice, unfortunately, mostly. Bare facts show that treated women after five years for every thousand women for six more cases of breast cancer. Not only combined hormone therapy, but treatment is based only on plant-based estrogen carries risk. However, it is lower. Use only powders with estrogenic activity increases the number of cases of breast cancer after five years of use of 1-2 cases per thousand women, and after ten years of use it is about 5 cases per 1000 women.
What follows? At least that for doctors, but also for every woman, the decision becomes more complicated. In addition to costs associated with the fact that that menopausal hormone therapy (progesterone) slightly reduces the risk of uterine cancer, her long-term use is linked to the contrary, a significant increase in risk of breast cancer. Roughly speaking, the riskier approach significantly improves the quality of life at a later age. Deciding women's definitely not easy now. Over the long-term hormonal treatment applied by the present method is beginning to raise a question mark. Perhaps more aptly - exclamation point!
It will be interesting to see how the results of a study stand manufacturers of the drugs, because there is new information also affected. Or the billions of profits. The author is still at large and not been declared legally incompetent, and it suggests a lot. FINDING RELIABLE GRAPHIC DESIGN COMPANY Web Templates: Designers Secret Weapon Charming Rajasthan Tours-Holding Impressive Attractions to Visit Insurance Quotes Motor - When Should It Be Best To Obtain One Punta Cana, Dominican Republic Elegant Holiday Leads Suites Deals Gastronomical Treats Plus Highligh Watch Cotto Vs Margarito 2 Live Stream Online, Replay Increase Claims Recovery With Subrogation Outsourcing: Drive Profitable Growth Personal Unsecured Loans Online-swift Cash To Support You A Lot Of Cum – Do You Want To Become A One Man BUKKAKE? Hazardous Waste Disposal Drives The Economy Buying Guide For Designer Bags Die Wahl Hemden Und Kinderbekleidung Fr Kleine Kids Business Trip Feels Like Home